Prescription Medicines Schedule




NEW ZEALAND GAZETTE, No. 77 — 3 AUGUST 2017

  • Paritaprevir
  • Pegaspargase
  • Peginterferon beta-1a
  • Pembrolizumab
  • Pentostatin
  • Phleum pratense extract
  • Pibrentasvir
  • Picibanil
  • Piperacetam
  • Pirfenidone
  • Ponatinib
  • Pralmorelin
  • Pramiracetam
  • Prilocaine; for injection except when used as a local anaesthetic in practice by a dental therapist or oral health therapist registered with the Dental Council; except when specified elsewhere in this notice
  • Ranitidine; except when specified elsewhere in this notice; except in medicines containing 300 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 7 days’ supply
  • Ramucirumab
  • Ranolazine
  • Recombinant human Epidermal Growth Factor
  • Rolipram (and its stereoisomers)
  • Rolziracetam
  • Rufinamide
  • Sacubitril
  • Sargramostim
  • Sarilumab
  • Secukinumab
  • Seletracetam (and its stereoisomers)
  • Sodium phenylbutyrate
  • Sodium zirconium cyclosilicate
  • Sonidegib
  • Stiripentol
  • Streptozocin
  • Sunifiram
  • Suvorexant
  • Talimogene laherparepvec
  • TB-500
  • Thymosin beta-4
  • Tizanidine
  • Tofacitinib
  • Trientine
  • Ulipristal
  • Velpatasvir
  • Venetoclax
  • Vorapaxar

Schedule 2

47



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2017, No 77





✨ LLM interpretation of page content

🏥 Schedule 1 - Prescription Medicines (continued from previous page)

🏥 Health & Social Welfare
Prescription Medicines, Schedule, Paritaprevir, Pegaspargase, Peginterferon beta-1a, Pembrolizumab, Pentostatin, Phleum pratense extract, Pibrentasvir, Picibanil, Piperacetam, Pirfenidone, Ponatinib, Pralmorelin, Pramiracetam, Prilocaine, Ranitidine, Ramucirumab, Ranolazine, Recombinant human Epidermal Growth Factor, Rolipram, Rolziracetam, Rufinamide, Sacubitril, Sargramostim, Sarilumab, Secukinumab, Seletracetam, Sodium phenylbutyrate, Sodium zirconium cyclosilicate, Sonidegib, Stiripentol, Streptozocin, Sunifiram, Suvorexant, Talimogene laherparepvec, TB-500, Thymosin beta-4, Tizanidine, Tofacitinib, Trientine, Ulipristal, Velpatasvir, Venetoclax, Vorapaxar

🏥 Schedule 2

🏥 Health & Social Welfare
Prescription Medicines, Schedule 2